Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Exposure to bioterrorism and mental health response among staff on Capitol Hill.

North CS, Pfefferbaum B, Vythilingam M, Martin GJ, Schorr JK, Boudreaux AS, Spitznagel EL, Hong BA.

Biosecur Bioterror. 2009 Dec;7(4):379-88. doi: 10.1089/bsp.2009.0031.

2.

Concerns of Capitol Hill staff workers after bioterrorism: focus group discussions of authorities' response.

North CS, Pollio DE, Pfefferbaum B, Megivern D, Vythilingam M, Westerhaus ET, Martin GJ, Hong BA.

J Nerv Ment Dis. 2005 Aug;193(8):523-7.

PMID:
16082296
3.

Capitol hill staff workers' experiences of bioterrorism: qualitative findings from focus groups.

North CS, Pollio DE, Pfefferbaum B, Megivern D, Vythilingam M, Westerhaus ET, Martin GJ, Hong BA.

J Trauma Stress. 2005 Feb;18(1):79-88.

PMID:
16281199
4.

In their own words: lessons learned from those exposed to anthrax.

Blanchard JC, Haywood Y, Stein BD, Tanielian TL, Stoto M, Lurie N.

Am J Public Health. 2005 Mar;95(3):489-95.

5.

Media exposure to bioterrorism: stress and the anthrax attacks.

Dougall AL, Hayward MC, Baum A.

Psychiatry. 2005 Spring;68(1):28-42.

PMID:
15899708
6.

Follow-up of deaths among U.S. Postal Service workers potentially exposed to Bacillus anthracis--District of Columbia, 2001-2002.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2003 Oct 3;52(39):937-8.

7.

Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001.

Jefferds MD, Laserson K, Fry AM, Roy S, Hayslett J, Grummer-Strawn L, Kettel-Khan L, Schuchat A; Centers for Disease Control and Prevention Anthrax Adherence Team.

Emerg Infect Dis. 2002 Oct;8(10):1138-44.

8.

Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, Semenova VA, Romero-Steiner S, Elie C, Quinn CP, Khabbaz R, Khan AS, Martin G, Eisold J, Schuchat A, Hajjeh RA.

Emerg Infect Dis. 2002 Oct;8(10):1039-43.

9.

Anthrax attack at the United States Capitol. Front line thoughts.

Anderson A, Eisold JF.

AAOHN J. 2002 Apr;50(4):170-3.

PMID:
11979645
10.

Public response to an anthrax attack: reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source.

SteelFisher G, Blendon R, Ross LJ, Collins BC, Ben-Porath EN, Bekheit MM, Mailhot JR.

Biosecur Bioterror. 2011 Sep;9(3):239-50. doi: 10.1089/bsp.2011.0005. Epub 2011 Aug 5.

PMID:
21819225
11.

Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Oct 26;50(42):909-19. Erratum in: MMWR Morb Mortal Wkly Rep 2001 Nov 2;50(43):962.

12.

The impact of anthrax attacks on the American public.

Blendon RJ, Benson JM, DesRoches CM, Pollard WE, Parvanta C, Herrmann MJ.

MedGenMed. 2002 Apr 17;4(2):1.

13.

No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

Baggett HC, Rhodes JC, Fridkin SK, Quinn CP, Hageman JC, Friedman CR, Dykewicz CA, Semenova VA, Romero-Steiner S, Elie CM, Jernigan JA.

Clin Infect Dis. 2005 Oct 1;41(7):991-7. Epub 2005 Aug 29.

PMID:
16142664
14.

A bitter pill to swallow: nonadherence with prophylactic antibiotics during the anthrax attacks and the role of private physicians.

Stein BD, Tanielian TL, Ryan GW, Rhodes HJ, Young SD, Blanchard JC.

Biosecur Bioterror. 2004;2(3):175-85.

PMID:
15588055
15.

The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.

Doolan DL, Freilich DA, Brice GT, Burgess TH, Berzins MP, Bull RL, Graber NL, Dabbs JL, Shatney LL, Blazes DL, Bebris LM, Malone MF, Eisold JF, Mateczun AJ, Martin GJ.

J Infect Dis. 2007 Jan 15;195(2):174-84. Epub 2006 Dec 6.

PMID:
17191162
16.

Postal workers' perspectives on communication during the anthrax attack.

Quinn SC, Thomas T, McAllister C.

Biosecur Bioterror. 2005;3(3):207-15.

PMID:
16181043
17.

The anthrax vaccine and research: reactions from postal workers and public health professionals.

Quinn SC, Thomas T, Kumar S.

Biosecur Bioterror. 2008 Dec;6(4):321-33. doi: 10.1089/bsp.2007.0064.

18.

The anthrax attacks 10 years later.

Bush LM, Perez MT.

Ann Intern Med. 2012 Jan 3;156(1 Pt 1):41-4. doi: 10.7326/0003-4819-155-12-201112200-00373. Epub 2011 Oct 3.

PMID:
21969275
19.

Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Nov 2;50(43):941-8. Erratum in: MMWR Morb Mortal Wkly Rep 2001 Nov 9;50(44):991.

20.

Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak.

M'ikanatha NM, Julian KG, Kunselman AR, Aber RC, Rankin JT, Lautenbach E.

BMC Public Health. 2005 Jan 5;5:2.

Supplemental Content

Support Center